NEW YORK, Jan. 20, 2016 (GLOBE NEWSWIRE) -- Kantar Health, a leading global healthcare consulting and market research firm, has named Michel Murino to the newly created role of CEO for Kantar Health Europe. In this strategic position, Murino will lead the organization's European business, strengthening its solutions and allowing the company to more synergistically address its clients' country-specific business issues in marketing insights, commercial effectiveness, real-world research and market access.
"The health and wellness industry is facing large-scale transformation, and organizational structures are shifting to adapt to these changes," said Lynnette Cooke, Global CEO, Kantar Health. "Today, our clients value the breadth of consulting services that Kantar Health can offer on a regional basis, while maintaining expertise of local market requirements and restrictions. Michel will lead a regional team to continue to evolve with the industry's needs."
"Healthcare today is more complex than ever before, and clients are challenged with disruptive forces at every level, ranging from a more empowered patient to regulatory hurdles to web-connected medical devices," Murino added. "Clients want a partner who can deliver a holistic view of the market. By bringing our European teams closer together, we'll deliver the best of Kantar Health to our clients and provide them with even greater value as they work to achieve their business goals."
Murino, who joined Kantar Health in 1999, previously served as CEO of Kantar Health's Southern Europe and France business unit. As CEO for Kantar Health Europe, all leaders of Kantar Health's European business units, including the recently acquired CEEOR business, will report to Murino.
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 600+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. Kantar Health is part of Kantar, the data investment management division of WPP. For more information, please visit www.kantarhealth.com.